This is an automatically translated article.
What disease does Sanrabe treat, can it treat stomach ulcers? In fact, Sanrabe with the main ingredient is Rabeprazole sodium, which has the effect of inhibiting gastric acid secretion and anti-ulcer. So what is Sanrabe, dosage and how to use it, learn through the article below.1. What disease does Sanrabe treat?
Sanrabe belongs to the group of gastrointestinal drugs, the main ingredient is Rabeprazole sodium. Active ingredient Rabeprazole has the effect of inhibiting gastric acid secretion and anti-peptic ulcer.
The drug has two types based on dosage:
Sanrabe 10 has the main ingredient Rabeprazole sodium 10mg. Sanrabe 20 has the main ingredient Rabeprazole sodium 20mg. Sanrabe is prepared in the form of enteric-coated tablets and is indicated for the treatment of peptic ulcer disease, peptic ulcer, Zollinger-Ellison syndrome, reflux esophagitis.
2. Usage and dosage of Sanrabe
Sanrabe drug is taken orally, take the tablet whole with water, do not break or chew or crush the medicine to drink.
Dosage of Sanrabe in adults is indicated depending on the severity of the disease, the starting dose is 10mg / day, then the dose can be increased to 20mg / day.
The duration of taking Sanrabe in the treatment of duodenal ulcer is from 4 to 8 weeks, for gastric ulcer and reflux oesophagitis is from 6 to 12 weeks.
3. Sanrabe side effects
Sanrabe medicine can cause some unwanted side effects such as urticaria, rash, hematological changes. Sanrabe also affects liver function, causing diarrhea, constipation, heaviness or bloating, and headaches.
If you see any unusual symptoms after taking Sanrabe, the patient should immediately report it to a doctor or go to a medical facility for examination.
4. Some notes when using Sanrabe
Do not use Sanrabe in people with hypersensitivity to the ingredients of the drug. Pregnant or lactating women and patients with liver failure should use caution when taking Sanrabe and the possibility of malignancy of gastric ulcer must be excluded. Sanrabe may interact with digoxin and increase blood levels of digoxin; with phenytoin may prolong the metabolism and excretion of phenytoin . The use of Sanrabe drug is to inhibit gastric acid secretion and anti-ulcer. Therefore, the drug is used in the treatment of reflux esophagitis, anastomosis, peptic ulcer disease, Zollinger-Ellison syndrome. Before using the drug, the patient should consult the doctor carefully for the drug to be effective.
